ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Hemant Surgical acquired a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.98 Crore. The deal expands the company's footprint into the precision oncology segment.
Hemant Surgical Industries completed the acquisition of Lifesenz Cancer Research Labs Private Limited. The target entity officially became a subsidiary effective June 01, 2026.
Hemant Surgical Industries will acquire a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.99 Crore. The acquisition strengthens its healthcare and cancer diagnostic segments.